|
LOC100128640 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.900100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.634200E-02 |
| Normal-vs-Stage2 |
6.144000E-01 |
| Normal-vs-Stage3 |
2.712600E-01 |
| Normal-vs-Stage4 |
8.155400E-01 |
| Stage1-vs-Stage2 |
5.989200E-01 |
| Stage1-vs-Stage3 |
7.449000E-01 |
| Stage1-vs-Stage4 |
5.891800E-01 |
| Stage2-vs-Stage3 |
5.813000E-01 |
| Stage2-vs-Stage4 |
9.110200E-01 |
| Stage3-vs-Stage4 |
6.138000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.658200E-02 |
| Normal-vs-AfricanAmerican |
2.251400E-01 |
| Normal-vs-Asian |
9.676000E-01 |
| Caucasian-vs-AfricanAmerican |
6.275600E-01 |
| Caucasian-vs-Asian |
5.201400E-01 |
| AfricanAmerican-vs-Asian |
6.079400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.724300E-02 |
| Normal-vs-Female |
6.465900E-02 |
| Male-vs-Female |
6.411400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.121600E-01 |
| Normal-vs-Extreme_Weight |
1.898800E-01 |
| Normal-vs-Obese |
6.323600E-02 |
| Normal-vs-Extreme_Obese |
3.379800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.868600E-01 |
| Normal_Weight-vs-Obese |
2.753400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.730800E-01 |
| Extreme_Weight-vs-Obese |
4.395000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.634200E-01 |
| Obese-vs-Extreme_Obese |
7.748000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.055500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.510280E-02 |
| Normal-vs-Age(61-80Yrs) |
3.047800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.874000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.795400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.419700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.663600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.368200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.048200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.794800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.058800E-03 |
| Normal-VS-Type2 PRCC |
8.795400E-01 |
| Normal-VS-KIRP CIMP |
1.988210E-02 |
| Normal-VS-Unclassified PRCC |
5.594800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.403300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.373900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.334000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.372700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.846000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.198000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.971000E-01 |
| Normal-vs-N1 |
3.524800E-01 |
| Normal-vs-N2 |
5.676600E-01 |
| N0-vs-N1 |
4.452200E-01 |
| N0-vs-N2 |
4.047600E-01 |
| N1-vs-N2 |
3.824200E-01 |
|
|
